X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16) 16
humans (15) 15
female (14) 14
middle aged (11) 11
adult (9) 9
oncology (9) 9
aged (8) 8
breast cancer (8) 8
male (7) 7
breast neoplasms - pathology (6) 6
cancer (6) 6
research article (6) 6
aged, 80 and over (5) 5
analysis (5) 5
medicine & public health (5) 5
retrospective studies (5) 5
animals (4) 4
breast neoplasms - genetics (4) 4
cancer therapies (4) 4
care and treatment (4) 4
cell line, tumor (4) 4
cells (4) 4
disease-free survival (4) 4
emergency medicine (4) 4
life sciences (4) 4
prognosis (4) 4
tumors (4) 4
activation (3) 3
biology and life sciences (3) 3
breast neoplasms - metabolism (3) 3
chemotherapy (3) 3
medical prognosis (3) 3
medicine (3) 3
metastasis (3) 3
methylation (3) 3
multidisciplinary sciences (3) 3
proteins (3) 3
research (3) 3
signal transduction (3) 3
survival (3) 3
tumorigenesis (3) 3
young adult (3) 3
[ sdv ] life sciences [q-bio] (2) 2
adolescent (2) 2
anesthesiology (2) 2
arginine (2) 2
arginine methylation (2) 2
bacteria (2) 2
biological diversity (2) 2
breast neoplasms - surgery (2) 2
cancer patients (2) 2
carcinoma, squamous cell - drug therapy (2) 2
carcinoma, squamous cell - pathology (2) 2
cell biology (2) 2
cell lines (2) 2
cisplatin - administration & dosage (2) 2
cisplatin - adverse effects (2) 2
cisplatin - therapeutic use (2) 2
cluster analysis (2) 2
clustering (2) 2
cohort studies (2) 2
correspondence (2) 2
development and progression (2) 2
drug administration schedule (2) 2
estrogen (2) 2
estrogen receptor alpha - genetics (2) 2
estrogen receptor alpha - metabolism (2) 2
follow-up studies (2) 2
genetics (2) 2
head and neck neoplasms - pathology (2) 2
health aspects (2) 2
identification (2) 2
intensive / critical care medicine (2) 2
kinases (2) 2
laurier, wilfrid, sir, 1841-1919 correspondence (2) 2
lavergne, emilie correspondence (2) 2
localization (2) 2
love-letters (2) 2
medicine and health sciences (2) 2
mice (2) 2
neoplasm recurrence, local - pathology (2) 2
neoplasm recurrence, local - prevention & control (2) 2
neoplasm staging (2) 2
nucleic acids (2) 2
observations (2) 2
organisms (2) 2
pathway (2) 2
patient outcomes (2) 2
pharmacology & pharmacy (2) 2
phosphatidylinositol 3-kinases - metabolism (2) 2
prime ministers (2) 2
proliferation (2) 2
radiochemotherapy (2) 2
radiology, nuclear medicine & medical imaging (2) 2
radiotherapy (2) 2
research articles (2) 2
science (2) 2
squamous-cell carcinoma (2) 2
survival rate (2) 2
toxicity (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 01/2017, Volume 12, Issue 1, p. e0168879
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 5/2019, Volume 27, Issue 5, pp. 1879 - 1889
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 07/2017, Volume 11, Issue 7, p. e0005764
Introduction Leishmania RNA virus type 1 (LRV1) is an endosymbiont of some Leishmania (Vianna) species in South America. Presence of LRV1 in parasites... 
COMPLETE SEQUENCE | DOUBLE-STRANDED-RNA | PARTICLES | LENGTH POLYMORPHISM ANALYSIS | SAMPLES | IDENTIFICATION | EPIDEMIOLOGY | SEVERITY | PARASITOLOGY | TROPICAL MEDICINE | REGION | Genome, Viral | Leishmaniavirus - classification | French Guiana | Humans | Middle Aged | Male | Phylogeny | Sequence Analysis, DNA | Leishmania - virology | Leishmaniavirus - genetics | Genetic Variation | Young Adult | Sequence Alignment | RNA, Viral - genetics | Adult | Female | Aged | Leishmaniasis - parasitology | Leishmaniavirus - isolation & purification | Leishmania - isolation & purification | Cluster Analysis | Immune response | Leishmania | Analysis | Research | Health aspects | Biological diversity | Drugs | Animal models | RNA | Laboratories | Pathogenesis | Funding | Taxonomy | Variability | Viruses | Identification | Genomes | Infections | Parasites | Immunity | Tropical diseases | Cutaneous leishmaniasis | Conserved sequence | Multinational space ventures | Historical account | Defence mechanisms | Parasitic diseases | Phylogenetics | Clusters | Evolution | Strains (organisms) | Bioinformatics | Species | Sequencing | Immune system | Vector-borne diseases | RNA viruses | Parasitology | Nucleotide sequence | Genetic diversity | Nucleic acids | Management | Leishmaniasis | Clustering | Ribonucleic acid--RNA | Failures | Virology | Medicine | Genotyping | Strains | Diagnostic systems | Molecular biology | Leishmaniavirus | Life Sciences | Microbiology and Parasitology | RNA, Viral | Genetics | Human genetics | Ribonucleic acid
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 24, pp. 35932 - 35945
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 11/2015, Volume 9, pp. 6203 - 6210
Background: Despite its toxicity, cisplatin every 3 weeks (q3w) is the standard potentiation of chemo-radiotherapy for head and neck squamous cell carcinoma.... 
Head and neck cancer | Chemoradiation | Cisplatin | Radiotherapy potentiation | radiotherapy potentiation | LOW-DOSE CISPLATIN | CHEMISTRY, MEDICINAL | head and neck cancer | POSTOPERATIVE RADIOTHERAPY | PHASE-III | CANCER | PRESERVATION | CONCOMITANT CHEMOTHERAPY | 3-WEEKLY CISPLATIN | RADIOCHEMOTHERAPY | PHARMACOLOGY & PHARMACY | LOCALLY ADVANCED HEAD | cisplatin | chemoradiation | CONCURRENT CHEMORADIOTHERAPY | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Cisplatin - administration & dosage | Radiation-Sensitizing Agents - therapeutic use | Young Adult | Radiation-Sensitizing Agents - administration & dosage | Antineoplastic Agents - adverse effects | Adult | Female | Retrospective Studies | Chemoradiotherapy - methods | Drug Administration Schedule | Head and Neck Neoplasms - therapy | Neoplasm Recurrence, Local | Carcinoma, Squamous Cell - therapy | Survival Rate | Radiation-Sensitizing Agents - adverse effects | Head and Neck Neoplasms - pathology | Disease-Free Survival | Cisplatin - therapeutic use | Cisplatin - adverse effects | Aged | Squamous cell carcinoma | Patient outcomes | Drug therapy | Radiotherapy | Observations | Methods | Drug synergism | Potentiation | Schedules | Mucositis | Hydration | Toxicity | Radiation | Weight loss | Metastasis | Radiation therapy | Dermatitis | Cancer therapies | Survival | Rank tests | Confidence intervals | Chemotherapy | Analgesics | Surgery | Renal failure | Alcoholic beverages | Head & neck cancer
Journal Article
Cancer Research, ISSN 0008-5472, 12/2012, Volume 72, Issue 23, pp. 6130 - 6141
Journal Article
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 11/2012, Volume 4, Issue 11, pp. 1200 - 1213
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2014, Volume 135, Issue 6, p. 1307
  Although the presence of nuclear estrogen receptor is widely used to guide breast cancer therapy, less attention has been paid to the receptor cytoplasmic... 
Breast cancer | Prognosis | Analysis | Estrogen | Kinases | Cancer therapies | Medical prognosis | Tumors
Journal Article